deltatrials
Terminated PHASE2/PHASE3 INTERVENTIONAL 1-arm NCT02878694

Treatment of Ptosis to Muscular Dystrophy Oculopharyngeal by Myoblast Autologous Graft (TTT-PT-DOP)

Sponsor: Centre Hospitalier Universitaire, Amiens

Conditions Muscular Dystrophy, Oculopharyngeal Ptosis
Interventions Myoblast autologous graft
Updated 7 times since 2017 Last updated: Nov 23, 2020 Started: Nov 14, 2019 Primary completion: Oct 9, 2020 Completion: Oct 9, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

insufficient recruitment

Other terminated trials from Centre Hospitalier Universitaire, Amiens

See all terminations from Centre Hospitalier Universitaire, Amiens

Listed as NCT02878694, this PHASE2/PHASE3 trial focuses on Muscular Dystrophy, Oculopharyngeal and Ptosis and remains terminated or withdrawn. Sponsored by Centre Hospitalier Universitaire, Amiens, it has been updated 7 times since 2019, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotActive Not Recruiting~Jun 2018 – ~Jan 2019 · 7 months · monthly snapshotActive Not Recruiting~Jan 2019 – ~Dec 2020 · 23 months · monthly snapshotUnknown Status~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshotTerminated~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

7 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE2/PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE2/PHASE3

    Phase: PHASE2_PHASE3 → PHASE2/PHASE3

  3. Jan 2021 — Jul 2024 [monthly]

    Terminated PHASE2_PHASE3

  4. Dec 2020 — Jan 2021 [monthly]

    Terminated PHASE2_PHASE3

    Status: Unknown Status → Terminated

  5. Jan 2019 — Dec 2020 [monthly]

    Unknown Status PHASE2_PHASE3

    Status: Active Not Recruiting → Unknown Status

▶ Show 2 earlier versions

  1. Jun 2018 — Jan 2019 [monthly]

    Active Not Recruiting PHASE2_PHASE3

  2. Jan 2017 — Jun 2018 [monthly]

    Active Not Recruiting PHASE2_PHASE3

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Centre Hospitalier Universitaire, Amiens
  • Groupe Hospitalier Pitie-Salpetriere
  • Rennes University Hospital
  • University Hospital, Brest
  • University Hospital, Caen
  • University Hospital, Lille
  • University Hospital, Rouen
Data source: University Hospital, Caen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations